BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28179964)

  • 1. Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy.
    Nieder C; Dalhaug A; Haukland E; Mannsaker B; Pawinski A
    J Clin Med Res; 2017 Mar; 9(3):183-187. PubMed ID: 28179964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival After Palliative Radiotherapy in Patients with Breast Cancer and Bone-only Metastases.
    Nieder C; Dalhaug A; Pawinski A; Mannsåker B; Haukland E
    In Vivo; 2016 11-12; 30(6):879-883. PubMed ID: 27815475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported symptoms before palliative radiotherapy predict survival differences.
    Nieder C; Kämpe TA; Pawinski A; Dalhaug A
    Strahlenther Onkol; 2018 Jun; 194(6):533-538. PubMed ID: 29344766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.
    Darlix A; Lamy PJ; Lopez-Crapez E; Braccini AL; Firmin N; Romieu G; Thezenas S; Jacot W
    BMC Cancer; 2016 Jul; 16():428. PubMed ID: 27387327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor marker analyses in patients with brain metastases: patterns of practice and implications for survival prediction research.
    Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A
    Tumour Biol; 2015 Aug; 36(8):6471-6. PubMed ID: 25801247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.
    Tampellini M; Berruti A; Gerbino A; Buniva T; Torta M; Gorzegno G; Faggiuolo R; Cannone R; Farris A; Destefanis M; Moro G; Deltetto F; Dogliotti L
    Br J Cancer; 1997; 75(5):698-702. PubMed ID: 9043027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
    Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
    Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
    Diel IJ; Solomayer EF; Seibel MJ; Pfeilschifter J; Maisenbacher H; Gollan C; Pecherstorfer M; Conradi R; Kehr G; Boehm E; Armbruster FP; Bastert G
    Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and prognostic factors of brain metastasis from colorectal cancer].
    Sun Z; Sun Y; Tan L; He J; Li X; She C; Li W
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):63-8. PubMed ID: 26796809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.
    Hulsbergen AFC; Lamba N; Claes A; Kavouridis VK; Lin NU; Smith TR; Verhoeff JJC; Broekman MLD
    World Neurosurg; 2019 Aug; 128():e157-e164. PubMed ID: 31035019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital.
    Bringolf L; Pestalozzi B; Fink D; Dedes K
    Swiss Med Wkly; 2016; 146():w14393. PubMed ID: 28102883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models.
    Nieder C; Kämpe TA
    Anticancer Res; 2018 Mar; 38(3):1705-1709. PubMed ID: 29491105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience.
    Enright K; Clemons M; Chow E
    Support Care Cancer; 2004 Jan; 12(1):48-52. PubMed ID: 14577020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer.
    Fehm T; Jäger W; Krämer S; Sohn C; Solomayer E; Wallwiener D; Gebauer G
    Anticancer Res; 2004; 24(3b):1987-92. PubMed ID: 15274389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and survival analysis of breast cancer molecular subtypes with hepatic metastases.
    Ge QD; Lv N; Kong YN; Xie XH; He N; Xie XM; Wei WD
    Asian Pac J Cancer Prev; 2012; 13(10):5081-6. PubMed ID: 23244114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.
    Griguolo G; Dieci MV; Giarratano T; Giorgi CA; Orvieto E; Ghiotto C; Berti F; Della Puppa A; Falci C; Mioranza E; Tasca G; Milite N; Miglietta F; Scienza R; Conte P; Guarneri V
    J Neurooncol; 2017 Jan; 131(2):369-376. PubMed ID: 27853958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.